TheFly.com
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
PALI
Palisade Bio
$
()
PALI
Palisade Bio announces expected upcoming milestones
PALI
5/13/2022 - 09:06am
Palisade Bio reports Q1 EPS (26c) vs ($1.45) last year
PALI
5/13/2022 - 09:06am
Palisade Bio announces $2M registered direct offering
PALI
5/6/2022 - 08:32am
Palisade Bio, Newsoara receive NMPA clearance for Phase 3 trial of LB1148
PALI
5/5/2022 - 08:44am
Palisade provides business outlook, highlights near-term pipeline advancements
PALI
5/2/2022 - 08:42am
Palisade Bio receives FDA 'Study May Proceed' letter for Phase 3 trial of LB1148
PALI
3/22/2022 - 08:32am
Palisade Bio files $100M mixed securities shelf
PALI
3/18/2022 - 16:45pm
Palisade Bio announces 2022 milestones
PALI
3/18/2022 - 08:35am
Palisade Bio reports 2021 EPS ($3.39) vs ($3.72) last year
PALI
3/18/2022 - 08:35am
Palisade Bio announces analysis of studies LBS-IST-POI-101, LBS-POI-201-CN
PALI
3/16/2022 - 08:11am
Palisade Bio adds Robert McRae as SVP, Operations, Strategic Development
PALI
,
VIRX
2/15/2022 - 08:47am
Palisade Bio to announces adhesions clinical data at SAGES 2022 meeting
PALI
2/8/2022 - 08:21am
Palisade Bio initiated with a Buy at Ladenburg
PALI
2/2/2022 - 06:40am
Palisade Bio granted U.S. patent covering LB1148
PALI
12/8/2021 - 08:10am
Palisade Bio announces EPO granted patent for LB1148
PALI
11/30/2021 - 08:06am
dynamic_feed
Breaking News
search
Search
menu
Menu